Informazioni sul prodotto
- 12'-Hydroxy-2'-(1-methylethyl)-5'-a-(2-methylpropyl)ergotaman-3',6',18-trione
- (2'Xi,12'Xi)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- (5'Alpha)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′,18-trione
- 12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- ALPHA-Ergocryptine
- Ergocryptine
- Ergokryptine
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α)-
- Vedi altri sinonimi
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- NSC 169479
- NSC 407319
- α-Ergokryptine
Ergocryptine is a dopamine receptor agonist with an active conformation that binds to the D2 and D3 receptors. It has been shown to be effective in treating some symptoms of Parkinson's disease, such as tremors and rigidity. Ergocryptine has also been shown to have a positive effect on the ovaries by inhibiting their function. This drug does not react chemically with zearalenone or guanylate, but it does inhibit cyclase activity, which leads to enhancement of the ergometrine reaction products.
Proprietà chimiche
Richiesta tecnica su: 3D-FE22782 a-Ergocryptine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.